The Shared Foundation: GHK-Cu + BPC-157 + TB-500 Both GLOW and KLOW are built on the same three-peptide base a combination that pairs the leading compounds from skin/anti-aging research and recovery research: This three-way base is studied for combining the major tissue-repair mechanisms gene expression (GHK-Cu), angiogenesis (BPC-157), and cell migration (TB-500) in a single formulation
The histamine H3 receptor: from gene cloning to H3 receptor drugs
Whats really expanding the appeal is the growing body of evidence around other health benefits: cardiovascular risk reduction, kidney disease, sleep apnea, and even early-stage trials for conditions like Alzheimers and addiction. New England Consulting Groups Stibel notes that diabetes and heart conditions are diseases that have noted benefits when it comes to GLP-1 medications, but that more research on other conditions is being done and it has been positive
In one recent case report, an ALS patient showed clinical improvement after receiving FMT, with better scores on the ALS Functional Rating Scale and lower levels of inflammation-related markers like CRP and IL-6 (Yan et al., 2024)
Benefits of MOTS-c: Reduces fat mass, particularly visceral fat , in animal and early human models Enhances glucose utilization Improves mitochondrial biogenesis May protect against age-related metabolic decline MOTS-c works by activating the AMPK pathway, which is critical for energy regulation and cellular health
c , Final three-dimensional density map coloured according to local resolution